117 related articles for article (PubMed ID: 7444943)
1. Shape changes of GSH-treated erythrocytes during complement-induced hemolysis.
Matsumoto N; Hiroshige Y
Tohoku J Exp Med; 1980 Oct; 132(2):199-205. PubMed ID: 7444943
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic properties of Ca(2+)-treated human erythrocytes under hydrostatic pressure.
Harano T; Yamaguchi T; Kimoto E
J Biochem; 1994 Oct; 116(4):773-7. PubMed ID: 7883751
[TBL] [Abstract][Full Text] [Related]
3. Shape and volume changes in rat erythrocytes induced by surface-active alkyltrimethylammonium salts and sodium dodecyl sulphate.
Isomaa B; Paatero G
Biochim Biophys Acta; 1981 Oct; 647(2):211-22. PubMed ID: 7295726
[TBL] [Abstract][Full Text] [Related]
4. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
Jenkins DE; Hartmann RC; Kerns AL
J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
[TBL] [Abstract][Full Text] [Related]
5. Biophysical correlates of lysophosphatidylcholine- and ethanol-mediated shape transformation and hemolysis of human erythrocytes. Membrane viscoelasticity and NMR measurement.
Chi LM; Wu WG; Sung KL; Chien S
Biochim Biophys Acta; 1990 Aug; 1027(2):163-71. PubMed ID: 2397228
[TBL] [Abstract][Full Text] [Related]
6. Interaction of dilauroylglycerophosphocholine with erythrocytes: pre-hemolytic events and hemolysis.
Tanaka Y; Inoue K; Nojima S
Biochim Biophys Acta; 1980 Jul; 600(1):126-39. PubMed ID: 7397164
[TBL] [Abstract][Full Text] [Related]
7. In vitro hemolysis of rat erythrocytes by selenium compounds.
Hu ML; Spallholz JE
Biochem Pharmacol; 1983 Mar; 32(6):957-61. PubMed ID: 6838660
[TBL] [Abstract][Full Text] [Related]
8. The effect of copper on intact swine erythrocytes.
Asano R; Hokari S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(2):443-7. PubMed ID: 2882948
[TBL] [Abstract][Full Text] [Related]
9. Complement-mediated aggregation of sensitized erythrocytes.
Gancevici GG
Arch Roum Pathol Exp Microbiol; 1985; 44(4):363-6. PubMed ID: 3838047
[No Abstract] [Full Text] [Related]
10. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
Lint TF; Behrends CL; Baker PJ; Gewurz H
J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
[TBL] [Abstract][Full Text] [Related]
11. Temperature-induced shape transformation of carrier erythrocytes.
Sprandel U
Res Exp Med (Berl); 1990; 190(4):267-75. PubMed ID: 2218076
[TBL] [Abstract][Full Text] [Related]
12. Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species.
Schiar VP; Dos Santos DB; Paixão MW; Nogueira CW; Rocha JB; Zeni G
Chem Biol Interact; 2009 Jan; 177(1):28-33. PubMed ID: 18983990
[TBL] [Abstract][Full Text] [Related]
13. Discocyte--echinocyte reversibility in blood stored in CPD over a period of 56 days.
Laczkó J; Feó CJ; Phillips W
Transfusion; 1979; 19(4):379-88. PubMed ID: 473341
[TBL] [Abstract][Full Text] [Related]
14. Hemin-mediated hemolysis in erythrocytes: effects of ascorbic acid and glutathione.
Li SD; Su YD; Li M; Zou CG
Acta Biochim Biophys Sin (Shanghai); 2006 Jan; 38(1):63-9. PubMed ID: 16395529
[TBL] [Abstract][Full Text] [Related]
15. Protection of wheat bran feruloyl oligosaccharides against free radical-induced oxidative damage in normal human erythrocytes.
Wang J; Sun B; Cao Y; Tian Y
Food Chem Toxicol; 2009 Jul; 47(7):1591-9. PubMed ID: 19371769
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis of normal human erythrocytes by autologous serum complement.
Kitamura H; Nagano A; Kitano E
Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
[TBL] [Abstract][Full Text] [Related]
17. The hemolytic activity of citral--II. Glutathione depletion in citral treated erythrocytes.
Segal R; Milo-Goldzweig I
Biochem Pharmacol; 1985 Dec; 34(23):4117-9. PubMed ID: 4062979
[TBL] [Abstract][Full Text] [Related]
18. Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.
Cunnion KM; Hair PS; Krishna NK; Sass MA; Enos CW; Whitley PH; Maes LY; Goldberg CL
Transfusion; 2017 Mar; 57(3):517-524. PubMed ID: 28000304
[TBL] [Abstract][Full Text] [Related]
19. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
Arroyave CM; Vallota EH; Müller-Eberhard HJ
J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
[No Abstract] [Full Text] [Related]
20. G6PD-deficiency infectious haemolysis: a complement dependent innocent bystander phenomenon.
Kasper ML; Miller WJ; Jacob HS
Br J Haematol; 1986 May; 63(1):85-91. PubMed ID: 3707864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
